IVIG Supplementation Reduces Infection Risk in Patients With Multiple Myeloma Receiving Teclistamab

Source: Pharmacy Times articles

For patients with multiple myeloma who may experience an infection while receiving teclistamab, supplementation with intravenous immunoglobulin (IVIG) can help resolve and prevent serious complications.
Read More